VIRMA promotes the progression of head and neck squamous cell carcinoma by regulating UBR5 mRNA and m6A levels. Biomol Biomed [Internet]. 2024 Sep. 6 [cited 2025 Apr. 16];24(5):1244–1257. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10358